Virus Archives - El·lipse

Pulmobiotics is a CRG spin-off that aims to develop therapeutic applications for lung diseases. Photo by Robina Weermeijer on Unsplash.

27.07.2020

Pulmobiotics: transforming a pathogen to fight lung disease

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.

21.05.2020

New study to assess the efficacy of ivermectin against COVID-19

Untrained staff performing the test will get an unequivocal result from the instrument. | Picture by the UPF.

15.05.2020

InstaCOVID19: UPF develops rapid diagnostic tests for SARS-CoV-2

So far, two recent studies suggest that hydroxychloroquine may be effective in reducing the viral load of SARS-CoV-2, although the results are inconclusive and further research is needed.

13.05.2020

New study to assess the efficacy of hydroxychloroquine in the prevention and treatment of COVID-19 during pregnancy

The latest book by physicist Ricard Solé, a researcher at the IBE, takes us into the world of viruses.

11.05.2020

Viruses: complex adaptive systems

Patients who received redemsivir had a 31% faster recovery time than those who received placebo. There was a 4-day reduction in hospital stay. | Picture by Francisco Avia.

08.05.2020

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

The developed tool, which is at the implementation phase, uses Artificial Intelligence technology to assist the diagnosis of COVID-19. | Picture by Geralt from Pixabay.

07.05.2020

Artificial Intelligence, a great ally in the diagnosis of COVID-19

| Edited picture from the National Cancer Institute on Unsplash.

07.04.2020

On Covid-19 research at the PRBB

07.04.2020

Making a contribution to Hospital del Mar to fight against the new coronavirus pandemic

A new study explains the evolution of virus-plant interactions in Mediterranean ecosystems by considering environmental fluctuations in each case. | Picture by Dengrz from Unsplash.

16.03.2020

Researchers model the role of the environment on the spread of viral infections in plants

60-90% of the adult world population is infected by cytomegalovirus. It is a latent and asymptomatic infection. | Picture by Qimono from Pixabay.

27.02.2020

New protection biomarker against cytomegalovirus in kidney transplant patients

Researchers find that NFAT5 helps control the levels of interferons during the immune response. Image by allinonemovie from Pixabay.

12.02.2020

New key element to control interferons during the immune response